GENE ONLINE|News &
Opinion
Blog

AAV
GeneOnline’s Weekly News Highlights: Sept 4-Sept 8
2023-09-12
Ginkgo Bioworks Adds StrideBio’s AAV Platform To Step Up Gene Therapy Development
2023-04-06
Novartis Bets $1.5 Billion on Voyager’s AAVs
2022-03-09
BIO CEO: Overcoming the Obstacles in Developing Gene Therapies
2022-02-21
What If Our Body’s Power Station Goes Wrong? Gene Therapy May Help
2022-02-15
Astellas Reveals Early Safety Data of Gene Therapy for Pompe Disease
2022-02-09
Novartis Books Gyroscope for $1.5 Billion in Pursuit of Gene Therapy for Blindness
2021-12-23
Harnessing Viral Evolution to Deliver Gene Therapy to Specific Tissues
2021-09-13
Serious Adverse Event in Study Participant Marks Latest Roadblock for Astellas’ Gene Therapy Trial
2021-09-03
Setting its Sights on Neurological Disorders, CRISPR Therapeutics Turns to an AAV Startup That Just Emerged Out of Stealth
2021-06-16
Biogen Inks $120 Million Pact with High Flying Ginkgo Bioworks to Redefine Manufacturing of Gene Therapy Vectors
2021-05-23
A Brief Sketch of Gene Therapy Vectors and Delivery Methods
2021-04-03
Sanofi Joins Hands with German Biotech to Develop Improved AAV Capsids for Gene Therapies
2021-02-28
Researchers Test Gene Augmentation Therapy in Patient-Derived Retinal Organoids to Find Eye Disease Cure
2021-02-23
Thermo Fischer Snags Novasep’s Low-Cost CMO for $879 Million
2021-01-17
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top